| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_880cc8535f892eca8121f608c316808c |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 |
| filingDate |
1997-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_370d8bab400afceab30518e17bb4831f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a08dd7be878a7fe04eca1728bab83ac
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_51ce30787db1d64b631376bb214e18e8 |
| publicationDate |
1998-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-9827096-A1 |
| titleOfInvention |
Method of preparation of physostigmine carbamate derivatives from eseroline ethers |
| abstract |
The present invention relates to a novel process for the preparation of physostigmine carbamate derivatives and to pharmaceutically acceptable salts thereof. The present invention further relates to a novel process for the preparation of eseroline derivatives and to pharmaceutically acceptable salts thereof. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8318768-B2 |
| priorityDate |
1996-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |